title: Sinusoidal obstructive syndrome prophylaxis with recombinant human soluble thrombomodulin is feasible in gemtuzumab ozogamicin-treated patients undergoing allogeneic hematopoietic cell transplantation.
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Yamamoto
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Matsuno
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: Y
authors.initials: Y
authors.lastname: Sugishita
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: R
authors.initials: R
authors.lastname: Kaneko
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: N
authors.initials: N
authors.lastname: Okamoto
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: M
authors.initials: M
authors.lastname: Koganesawa
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: S
authors.initials: S
authors.lastname: Fujita
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Akiyama
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: D
authors.initials: D
authors.lastname: Toyama
authors.affiliation: Department of Pediatrics, Showa University Fujigaoka Hospital, Yokohama, Japan.
authors.forename: K
authors.initials: K
authors.lastname: Isoyama
mesh_terms: D000293:Adolescent; D064591:Allografts; D000617:Aminoglycosides / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D005260:Female; D000079982:Gemtuzumab; D018380:Hematopoietic Stem Cell Transplantation; D006504:Hepatic Veno-Occlusive Disease / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D007223:Infant; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D008297:Male; D011994:Recombinant Proteins / Q000008:administration & dosage; D018180:Thrombomodulin / Q000008:administration & dosage*
chemical_list: D000617:Aminoglycosides; D061067:Antibodies, Monoclonal, Humanized; D011994:Recombinant Proteins; C546931:THBD protein, human; D018180:Thrombomodulin; D000079982:Gemtuzumab